Cambrex (CBM) Shows Strength: Stock Adds 6.5% in Session
Cambrex Corporation.CBM was a big mover last session, as its shares rose over 6% on the day. The upside was driven by the company's announcement of encouraging third-quarter 2015 financial results. This also led to far more shares changing hands than in a normal session. Yesterday's rally continues the uptrend for the company since Oct 22, as the stock is now up almost 17%.
Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Cambrex currently has a Zacks Rank #3 (Hold).
A better-ranked biomedical stock is Actelion Ltd. ALIOF with a Zacks Rank #1 (Strong Buy).